Denise Van Dijk

Denise van Dijk is the President of the Female Health Company, the manufacturer of the FC2 female condom. She is the main liaison for governments, donors, and civil society in setting up sustainable female condom programs. Half American, Half Dutch, Denise has worked in many countries all over the world in SRHR for multiple NGOs, private sectors, as well as a consultant to governments.

The Female Health Company is the global public sector division of Veru. FHC focuses on the programming, manufacturing and advocacy of the FC2 female condom. Its main clients are found in governments, large global agencies and private distributors. Since the launch of the FC2 female condom, the product has been shipped to over 144 countries worldwide.

Recent Posts

Any thoughts? Contact us to learn more about the submission process.
The IMPT is the first & only initiative dedicated to advancing the field of multipurpose prevention technologies (MPTs), products that combine HIV prevention, other STI prevention, and contraception.

IMPT Secretariat
1750 Howe Avenue, Suite 550
Sacramento, CA 95825

The Initiative for Multipurpose Prevention Technologies (IMPT) is a project of CAMI Health, a social impact organization dedicated to improving the health of women and their families worldwide. CAMI Health is housed at the Public Health Institute (PHI).

This project is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of Cooperative Agreement #AID-OAA-A-16-00045. The contents are the responsibility of the IMPT, CAMI Health, PHI, and its partners and do not necessarily reflect the views of USAID or the U.S. Government.
© Copyright 2020, Public Health Institute / CAMI Health / IMPT Secretariat. All rights reserved.